A Non-interventional Trial of Erlotinib (Tarceva) Metastatic Non-small Cell Lung Cancer
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
This is a non-interventional, open label, single arm, multicenter study to assess the safety
and efficacy of erlotinib in participants with non-small cell lung cancer.